Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lucie Gorisse-Hussonnois"'
Autor:
Léa Huguet, Lidia Tagliafierro, Stéphanie Chasseigneaux, David Geny, Fabian Corlier, Marie-Claude Potier, Vincent Contremoulins, Florian Rebeillard, Lucie Gorisse-Hussonnois, Michèle Darmon, Aysegul Dilsizoglu Senol, Bernadette Allinquant
Publikováno v:
Cellular and Molecular Life Sciences. 76:4995-5009
Protein interacting with Amyloid Precursor Protein (APP) tail 1 (PAT1) also called APPBP2 or Ara 67 has different targets such as APP or androgen receptor and is expressed in several tissues. PAT1 is known to be involved in the subcellular traffickin
Autor:
Lucie Gorisse-Hussonnois, Mickael Audrain, Jérôme Braudeau, Emilie Dorard, Bernadette Allinquant, Christiane Rose, Nathalie Cartier
Publikováno v:
Neurobiology of Aging. 61:23-35
Amyloid precursor protein (APP), a key molecule of Alzheimer disease, is metabolized in 2 antagonist pathways generating the soluble APP alpha (sAPPα) having neuroprotective properties and the beta amyloid (Aβ) peptide at the origin of neurotoxic o
Autor:
Thierry Pillot, Emilie Dorard, Cédric Broussard, Lucie Gorisse-Hussonnois, Stéphanie Chasseigneaux, Bernadette Allinquant
Publikováno v:
Molecular Neurobiology. 55:5594-5610
Amyloid precursor protein (APP) is cleaved not only to generate the amyloid peptide (Aß), involved in neurodegenerative processes, but can also be metabolized by alpha secretase to produce and release soluble N-terminal APP (sAPPα), which has many
Autor:
Chantal Guihenneuc-Jouyaux, Christelle Albac, Lucie Gorisse-Hussonnois, Emilie Dorard, Bernadette Allinquant, Marie-Claude Potier
Publikováno v:
Neurobiology of Aging
Neurobiology of Aging, Elsevier, 2016, 46, pp.43-48. 〈10.1016/j.neurobiolaging.2016.06.010〉
Neurobiology of Aging, 2016, 46, pp.43-48. ⟨10.1016/j.neurobiolaging.2016.06.010⟩
Neurobiology of Aging, Elsevier, 2016, 46, pp.43-48. ⟨10.1016/j.neurobiolaging.2016.06.010⟩
Neurobiology of Aging, Elsevier, 2016, 46, pp.43-48. 〈10.1016/j.neurobiolaging.2016.06.010〉
Neurobiology of Aging, 2016, 46, pp.43-48. ⟨10.1016/j.neurobiolaging.2016.06.010⟩
Neurobiology of Aging, Elsevier, 2016, 46, pp.43-48. ⟨10.1016/j.neurobiolaging.2016.06.010⟩
International audience; SET is a multifunctional protein, but when present in the cytoplasm, acts as a powerful inhibitor of phosphatase 2A. We previously observed that in CA1 of Down syndrome (DS) patients, the level of SET is increased, and SET is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6db228e691aa36e18a3ff683ff7a607d
https://hal.sorbonne-universite.fr/hal-01357903/document
https://hal.sorbonne-universite.fr/hal-01357903/document
Autor:
Christine Clamagirand, Léa Huguet, Stéphanie Chasseigneaux, Lucie Gorisse-Hussonnois, Bernadette Allinquant, Christiane Rose
Publikováno v:
BMC Neuroscience
BMC Neuroscience, 2014, 15 (1), pp.82. ⟨10.1186/1471-2202-15-82⟩
BMC Neuroscience, 2014, 15 (1), pp.82. ⟨10.1186/1471-2202-15-82⟩
International audience; Background: The neuronal cytoplasmic localization of SET, an inhibitor of the phosphatase 2A (PP2A), results in tau hyperphosphorylation in the brains of Alzheimer patients through mechanisms that are still not well defined.Re